Overall Technical outlook

Price Summary

Gland Pharma Limited's stock began trading at 1855.0 on 2026-02-27, soared to 1855.0, dipped to 1808.8, and finished the day -1.77% down at 1822.2, with 118031 shares exchanged.
Over the course of 52 weeks, the stock peaked at 2102.1 and hit a low of 1392.8.
The projected price range for Gland Pharma Limited is between 1525.0 and 2500.0, with an expected mean price of 1964.3077, according to 13 analysts.

Technicals

Support and Resistance: The price for GLAND at 1822.2 finds support at 1769.8 and resistance at 1895.7. This suggests a trading range, where 1769.8 serves as a support level and 1895.7 acts as a resistance point, potentially capping further gains.
GLAND supportResistance fb8cd3
Support/Resistance for GLAND


Aroon: The AROON is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
GLAND aroon fb8cd3
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance for GLAND, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
GLAND bbands fb8cd3
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR remains bearish, establishing a resistance level that could cap any potential upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for GLAND.
GLAND psar fb8cd3
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The current state of the STOCHASTIC is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
GLAND stoch fb8cd3
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
GLAND trippleSMA fb8cd3
Tripple SMA chart for Gland Pharma Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.